Real-World Experience of the One-Year Efficacy of Rifaximin Add-On to Lactulose Is Superior to Lactulose Alone in Patients with Cirrhosis Complicated with Recurrent Hepatic Encephalopathy in Taiwan

Real-World Experience of the One-Year Efficacy of Rifaximin Add-On to Lactulose Is Superior to Lactulose Alone in Patients with Cirrhosis Complicated with Recurrent Hepatic Encephalopathy in Taiwan

Background: Hepatic encephalopathy (HE), a neuropsychiatric complication of decompensated cirrhosis, is associated with high mortality and high risk of recurrence. Rifaximin add-on to lactulose for 3 to 6 months is recommended for the prevention of recurrent episodes of HE after the second episode....

Full description

Bibliographic Details
Main Authors: Ching Chang, Chien-Hao Huang, Hsiao-Jung Tseng, Fang-Chen Yang, Rong-Nan Chien
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Journal of Personalized Medicine
Subjects:
rifaximin
lactulose
cirrhosis
hepatic encephalopathy
Taiwan
Online Access:https://www.mdpi.com/2075-4426/11/6/478

Internet

https://www.mdpi.com/2075-4426/11/6/478

Similar Items